MIFH
GRTX

Migdal Insurance & Financial Holdings’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,322
Closed -$11K – 744
2021
Q3 		$11K Buy
+1,322
New +$11.3K ﹤0.01% 592

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Migdal Insurance & Financial Holdings's GRTX Position: Q4 2021 in Review

Migdal Insurance & Financial Holdings sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 1,322 shares — an estimated $11K sold.

Migdal Insurance & Financial Holdings first reported a position in GRTX in Q3 2021 and held it in 1 quarter. The position peaked at $11K in Q3 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1,322 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $11K.
  • Migdal Insurance & Financial Holdings first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's Galera Therapeutics, Inc. Common Stock position peaked at $11K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2021, filed 2 Feb 2022.